Why is Kobo Biotech falling/rising?

As of 24-Sep, Kobo Biotech Ltd's stock price is currently at 2.38, reflecting an increase of 0.11 or 4.85%. The stock has outperformed its sector today by 5.34%, although it is trading higher than its 5-day and 20-day moving averages but lower than its longer-term moving averages (50-day, 100-day, and 200-day). Despite this positive movement, the company has not declared results in the last six months, indicating weak long-term fundamental strength. The stock has shown poor growth with net sales declining at an annual rate of -100% and an operating profit of 0% over the past five years. Additionally, the company has high debt levels, and its recent quarterly results have been disappointing, with both operating and pre-tax profits at their lowest levels.
In the broader market context, Kobo Biotech's short-term return of +4.85% over the past week contrasts sharply with the Sensex, which has declined by 1.18% during the same period. However, the stock has consistently underperformed against the benchmark over the last three years, with a significant decline of -56.88% compared to the Sensex's gain of +40.65%. This persistent underperformance, coupled with a lack of recent financial disclosures and a significant drop in investor participation, suggests that while there may be short-term gains, the long-term outlook remains precarious for Kobo Biotech.